Case report
Open access
Aug 2026
The Utilization of Inclisiran for the Optimization of Lipid Management in People Living with HIV: A Clinical Case Series and Comprehensive Review
These cases illustrate that inclisiran can effectively lower LDL-C levels across primary and secondary prevention settings in PWH facing oral therapy limitations or statin intolerance, supporting the inclusion of PWH in broader clinical pathways pending ongoing cardiovascular outcome trials.
Vasileios Petrakis, M. Panopoulou, A. Grapsa et al.
· Reports · 1 citation